Literature DB >> 20353981

Non-criteria manifestations of antiphospholipid syndrome.

D Erkan1, M D Lockshin.   

Abstract

Only few studies have addressed the pathogenesis and treatment of the non-criteria manifestations of antiphospholipid antibodies (aPL) such as thrombocytopenia, nephropathy, cardiac valve disease, cognitive dysfunction, skin ulcers, or diffuse pulmonary hemorrhage. There is no consensus on the management of these manifestations; they may occur despite full-dose anticoagulation or may not improve if anticoagulation is initiated after their discovery. This brief review may help physicians in the management of the non-criteria manifestations of aPL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353981     DOI: 10.1177/0961203309360545

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  18 in total

Review 1.  Difficult clinical situations in the antiphospholipid syndrome.

Authors:  Renata Ferreira Rosa; Michelle Remião Ugolini-Lopes; Audrey Krüse Zeinad-Valim; Elbio D'Amico; Danieli Andrade
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

2.  Diffuse alveolar haemorrhage and Libman-Sacks endocarditis: a rare presentation of antiphospholipid syndrome.

Authors:  Brianna Bielski; Nikhil H Shah; Donevan Westerveld; Carolyn Stalvey
Journal:  BMJ Case Rep       Date:  2018-05-07

3.  The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.

Authors:  Ozan Unlu; Doruk Erkan; Medha Barbhaiya; Danieli Andrade; Iana Nascimento; Renata Rosa; Alessandra Banzato; Vittorio Pengo; Amaia Ugarte; Maria Gerosa; Lanlan Ji; Maria Efthymiou; D Ware Branch; Guilherme Ramires de Jesus; Angela Tincani; H Michael Belmont; Paul R Fortin; Michelle Petri; Esther Rodriguez; Guillermo J Pons-Estel; Jason S Knight; Tatsuya Atsumi; Rohan Willis; Stephane Zuily; Maria G Tektonidou
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-01       Impact factor: 4.794

4.  Neonatal septic arthritis: Indian perspective.

Authors:  Akash Rai; Debrup Chakladar; Souravi Bhowmik; Tanushree Mondal; Arnab Nandy; Biplab Maji; Avijit Hazra; Rakesh Mondal
Journal:  Eur J Rheumatol       Date:  2019-09-05

Review 5.  AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update.

Authors:  Medha Barbhaiya; Danieli Andrade; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2016-10       Impact factor: 4.592

Review 6.  Clinical assessment and management of cytopenias in lupus patients.

Authors:  Alana B Levine; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2011-08       Impact factor: 4.592

Review 7.  Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.

Authors:  Michael D Lockshin
Journal:  Clin Lab Med       Date:  2013-04-19       Impact factor: 1.935

8.  Impact of antiphospholipid syndrome iBook on medical students' improvement of knowledge: An international randomized controlled study.

Authors:  Stephane Zuily; Laurent Phialy; Ecem Sevim; Eloïse Germain; Ozan Unlu; Virginie Dufrost; Jessie Risse; Isabelle Clerc-Urmès; Cédric Baumann; Jessica R Berman; Michael D Lockshin; Denis Wahl; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2019-09-05

Review 9.  Antiphospholipid syndrome; its implication in cardiovascular diseases: a review.

Authors:  Ioanna Koniari; Stavros N Siminelakis; Nikolaos G Baikoussis; Georgios Papadopoulos; John Goudevenos; Efstratios Apostolakis
Journal:  J Cardiothorac Surg       Date:  2010-11-03       Impact factor: 1.637

Review 10.  The Role of Antiphospholipid Antibodies in COVID-19.

Authors:  Maximilian Stelzer; Jörg Henes; Sebastian Saur
Journal:  Curr Rheumatol Rep       Date:  2021-07-14       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.